Search results for:
2022 Seville (Spain)
Presentations
September 18
Pharmacy in Spain
1 - The pharmacist profession in Spain in 2022: We are Pharmacists
2 - We are Pharmacists: We Provide Care
3 - The Social Impact of Pharmacy in Spain: We are Social
4 - Digital Agenda for the Pharmaceutical Profession: Transformation through Action
5 - Digital pharmacy projects in Spain
6 - Pharmacy’s experience and lessons learnt during the COVID-19 pandemic
7 - We are Pharmacists: Communication as a lever for transformation
September 19
No Borderline–Barriers in pharmaceutical care
Plenary: Pharmacy united in recovery of healthcare system (AP1)
Multidisciplinary perspectives and the emerging role of pharmacists in global health
Perspectives from Shot@Life on learnings and challenges from the pandemic, opportunities for pharmacy
Your perspective on learnings through the pandemic with the imperative for your organisation and for pharmacy
Integration of community pharmacy into primary health care: challenges due to COVID 19 and opportunities for the future (A1)
Educational needs and opportunities — Preparing the workforce of the future (A2)
New clinical aspects in teaching and learning
Practice of pharmacy/pharmaceutical education during the Corona pandemic
Beyond COVID: Catalysing vaccine technology and drug delivery (A3)
Brazilian advances on regulation of vaccine and medicines
Overview of mRNA COVI-19 vaccine, cell-based gene therapy, and future oncology therapeutics development
Quality platforms to support hospitals in managing COVID 19: Learnings and opportunities (A4)
It’s not enough to be ethical, we also need to be socially responsible. (A5)
Prospects of innovative pharmaceutical sciences to combat global health challlenges in the future (A6)
Bridging the technology gap for improved global health response in Africa
Quantitative Systems Pharmacology to Accelerate Drug Development for Emerging Global Health Challenges
Technology Forum: How digital health is changing care delivery for pharmacists and improving public health (LS-M3)
Benefits of technology in hospital pharmacy
Digital Science, accelerating medicine discovery
Digital services within the community pharmacy
How will digital health apps change the pharmacist/patient relationship
September 20
Plenary: Leading in times of crisis (BP2)
Supporting the profession to deliver UHC and the lessons learnt during the pandemic
The EPhEU campaign- Medicines to Ukraine working with Pharmacists Without Borders, Cafod and Caritas to organise the initiative
The EPhEU campaign- Medicines to Ukraine working with Pharmacists Without Borders, Cafod and Caritas to organise the initiative
Defining the role of pharmacists in future public health emergencies (B10) (B1)
A unique approach to the pandemic: Lessons from Australia
Pharmacists emergency preparedness and response in pandemics
Equitable access to medicines: managing medicines shortages (B7)
Pharmacists Response to Medication Shortages Amid COVID-19
The potential of Prospective Risk Assessments for addressing medicine shortages
Finding the humanitarian face of pharmacy (B8)
Managing the pandemic as a Humanitarian Aid Pharmacist
The humanitarian pharmacy in international conflicts: Intervention in Ukraine.
Health technology assessments and rapid access to medicines (B9)
Combatting the mental and behavioural health crisis: the path forward (B11)
Bidirectional feedback between students and academics: promoting better mental health and resilience during pandemic"
The integration of pharmacists’ in mental health care: Triumphs and challenges
New Technologies to enable better care (B12)
Military Pharmacy’s Contributions to the Profession and a Healthy Society.
Use of unapproved drugs during military and civilian emergency situations
Global, regional and national perspectives on the road map ahead for a global action plan in AMR (LS-T2)
No Borderline–Barriers in pharmaceutical care (LS-M2)
Shared experiences and lessons learnt during the pandemic: Preparing for the unexpected (T1)
Lessons learned from Covid-19 and other disasters and going forward
Lessons learned from Covid-19 and other disasters and going forward
Shared experiences and lessons learnt during the pandemic: Mental health challenges (T2)
Mental health, the impact on health professions: WHPA and the ways we can respond to our professions’ needs
Resilience of the pharmaceutical workforce pre, during and post the pandemic
Suicide prevention: are pharmacy teams an overlooked and indispensable asset?
September 21
Plenary: Capturing the breadth and depth of digital health beyond the pandemic (CP3)
Digital health as an enabler of self-care literacy: The benefits and risks to equity of self-care and the role pharmacy can play
Equity and ageing — The opportunities and risks of technology and digital health in support for older populations
Social media and pharmacists’ roles in the infodemic (C13)
Shared decision making: how do we ensure culturally appropriate information and services? (C14)
Learning to look through the patient’s lens: Approaches to patient-centered cultural care
New pharmacist attributes necessary for effective patient counselling and education and introduce the audience to the concept of mentalizing
Are intellectual property rights justifiable in public health emergencies? (C15)
Do patents impede responses/access in public health emergencies?
The value of intellectual property and voluntary licencing in addressing global health emergencies
Reinventing primary health care, reinventing pharmacy (C16)
New funding models for community pharmacies services: lessons from Covid-19 pandemic
The role of community pharmacy in a reinvented primary health care system
Artificial intelligence in pharmacy practice: Current developments and trends (C17)
The safe handling of new and emerging therapeutics: from mRNA to cell based treatments (C18)
Challenges and opportunities for use of closed system drug transfer-devices (CSTDs) with biological agents
Comparison of biosafety and hazardous drug safe handling procedures
Shared experiences and lessons learnt during the pandemic: Health equity (T3)
Pharmacy transformation in Egypt
Vaccine Hesitancy and Vaccine Administration by Pharmacists: Lessons from COVID-19
Shared experiences and lessons learnt during the pandemic: Expanding horizons (T4)
A U.S. Hospital’s pandemic response: pharmacy steps up
How COVID-19 pandemic changes The Indonesian Pharmacists Association in maintaining professionalism of the pharmacy workforce
Posters
Academic pharmacy
A case study evaluation of the UW-Madison comparative health systems global pharmacy fellowship program (APS-043)
A comparative analysis of professional background and experience for the responsible person position in pharmaceutical wholesale distribution (APS-071)
A support programme for effective student learning in a problem-based pharmacy curriculum at a South African university (APS-075)
A SYSTEMATIC REVIEW OF CONTEMPORARY COMPETENCY-BASED EDUCATION FOR PHARMACY PRACTITIONERS AND STUDENTS (APS-087)
A systematic review of the assessment tools for examining the quality of learning environment in health professions education (APS-051)
Academic fraud during online learning among medical and pharmaceutical students in higher education (Russian federation, republic of Belarus) (APS-054)
An analysis of mentoring needs of UK pharmacists (APS-021)
An innovative e-learning continuing professional development (CPD) platform designed for pharmacists (APS-083)
An interdisciplinary academic initiative: seminar on vaccinology as relevant to COVID-19 (APS-029)
Antidyslipidemia effect of decoction of mango leaves cultivar Manalagi mangifera indica l. var. Manalagi (APS-066)
Antihyperglicemic effect of African leaves (Vernonia amygdalina del.) Kombucha in mice (APS-067)
Applications of social theories of learning to foster students’ professional identity in health professions education programs: a scoping review (APS-052)
Assessment of mental wellbeing and its associated factors: an international survey of undergraduate pharmacy students from 14 countries (APS-026)
Better together: creating an equity, diversity, and inclusion statement for PharmAlliance, an international partnership between three schools of pharmacy (APS-060)
Blended intensive program: professionals mentoring students to discover their career opportunities worldwide (APS-057)
Characteristics of successful international partnerships based on the five pillars of global health engagement (APS-037)
Charting the course and preparedness for recognition of global leaders: creating and charging the phi lambda sigma international affairs committee (APS-077)
Conducting and evaluating a conceptual training programme for pharmacists as vaccinators in Ghana (APS-027)
Creation of a Spanish language track program for Purdue university student pharmacists (APS-061)
Design and optimisation of novel MEK inhibitors for the management of neoplastic disease using the tak-733 scaffold as a lead molecule (APS-079)
Determination of Smoking Habits and Nicotine Addiction Status of Pharmacy Students (APS-088)
Developing a patient safety culture training curriculum for healthcare professionals (APS-035)
Developing a risk management course for forensic professionals (APS-013)
Development of a comprehensive instrument to evaluate existing international experiential training sites (APS-018)
Development of a survey to categorize global activities in professional pharmacy students (APS-017)
Development of an advanced diabetes certificate-training program focusing on the use of pattern management in a tele-practice setting (APS-046)
Differences in pharmacy students’ ability to detect, resolve and prevent drug-related problems after theoretical and practical courses during the final year of the graduate program (APS-064)
Digital delivery of clinical assessment and consultations skills for community pharmacists in England (APS-072)
Embedding Deai in student pharmacist professional development (APS-031)
Evaluation of a novel teaching module: the art of pharmacy (APS-009)
Evaluation of grit and its associated factors: an international survey of undergraduate pharmacy students from 14 countries (APS-025)
Evaluation of the impact of professional training (APS-082)
Expanding the utilization of the doctorate of pharmacy degree in varying healthcare fields through a preceptor showcase for rising APPE students (APS-073)
Exploring pharmacy students’ perception of pharmacists’ roles to support professional identity formation using an arts-informed method (APS-063)
Exploring the development of professional identity in pharmacy students (APS-010)
Exploring views on moral development from newly qualified pharmacist to established practitioner (APS-039)
Factor analysis structure and psychometric properties of a resilience scale among pharmacy students and academics in the eastern Mediterranean region (APS-011)
Foundation for pharmaceutical education in Mexico A.C-Fefarm (APS-032)
From pharmacy student to pharmacist: exploring the journey of moral development (APS-040)
Health education via public service announcement, telehealth education, and digital health video project in doctor of pharmacy education (APS-078)
Healthcare providers’ perception of hand sanitization during COVID-19 pandemic: pharmacists' gaps of knowledge (APS-024)
How the pandemic is influencing the delivery of practical training for pharmacists – a look at the masterclass series by the Ghana College of Pharmacists (APS-028)
Impact of social distancing and quarantine on students’ well-being and mental health during COVID-19 (APS-002)
Impact of virtual learning on pharmacy education: assessment of examination scores before, during, and after the COVID-19 pandemic (APS-014)
Implementation of an inter-professional health and wellness festival at school of pharmacy and health professions (APS-081)
Improved knowledge on substandard and falsified (sf) medical products through a dedicated course for pharmacy students at three universities in sub-Saharan Africa (APS-047)
In future I will have more understanding of people living with dementia: an experiential learning activity on dementia for first year mPharm students. (APS-084)
In silico design and validation of novel cyclin dependent kinase (DC) receptor inhibitors, using the palbociclib scaffold as a lead for the management of breast cancer (APS-080)
Integrating hospital pharmacy training into undergraduate and graduate pharmaceutical courses in china (APS-074)
Integration and internationalization: an international summer program integrating four pharmacy disciplines (APS-041)
Knowledge and attitudes of Croatian students towards epilepsy: cross sectional comparison study (APS-044)
Knowledge, attitudes and practices of final year bachelor of pharmacy students about antimicrobial resistance and antimicrobial stewardship (APS-036)
Leveraging technology to advance patient care in the developing world: a new community platform for pharmacy workforce education (APS-008)
Longitudinal educational aptitude development: taking the lead on curricular relevance – faculty perceptions (APS-033)
Longitudinal educational aptitude development: taking the lead on curricular relevance – students impression (APS-069)
Longitudinal educational aptitude development: taking the lead on curricular relevance--preceptor perceptions (APS-022)
On difficulty: pharmacy students’ struggles within the mPharm curriculum (APS-085)
Outcomes of FIP PharmaBridge exchange programs based on program hosts’ and participants’ surveys (APS-068)
Parsing the pandemonium: an analysis of student perceptions of online teaching and learning (APS-034)
Perceptions of healthcare professional students on stigma surrounding substance use disorders: a qualitative study in the United States of America (APS-020)
Pharmaceutical care supervised projects in the pharmacy curriculum and FIP sustainable development goals (APS-050)
Pharmacovigilance teaching-learning: a mixed cross-sectional analysis in Portuguese healthcare students and professionals (APS-056)
Pharmacy students stress level during COVID-19 returning from online to onsite learning in Iraq: a cross-sectional study (APS-007)
Professional identity formation: using a community EPA based IPPE assessment (APS-023)
Provider experiences of changes to qualifications for pharmacy support personnel in South Africa (APS-030)
Quality improvement innovation in pharmacy education 4.0 (APS-015)
Remote versus onsite learning: a retrospective review on student achievement and academic integrity (APS-070)
Revalidation requirements for pharmacists in Spain: suggestions of the official pharmacists’ chamber of Burgos (Spain) (APS-076)
Social concern about anxiolytic abuse as a strategy to improve student learning of pharmacology (APS-012)
Strengthening student professional engagement during COVID-19 pandemic (APS-045)
Students’ attitude toward CPD and preparedness to become life-long learners scale (SPLLL): a multinational study (APS-055)
Supporting equity, diversity, and inclusion in academic pharmacy: utilization of an institute model to provide training and action-planning for faculty. (APS-065)
Supporting our teaching staff: aligning educational scholarship and teacher development (APS-048)
Teaching and learning across time zones: a collaborative online international pharmacy course (APS-042)
The debate as a pedagogy in clinical pharmacy (APS-005)
The impact of an international experience on career development of student pharmacists (APS-062)
The perception of pharmacy undergraduate students to teaching activities and OSCE assessment on medication reconciliation. (APS-053)
This has helped me realise that my beliefs are strong, but I need to put them aside and think what is best for the patient: learning about spirituality for third year mPharm students. (APS-086)
Toward student centred pedagogies in pharmacy education (APS-006)
Training African women as health agents in Africa (APS-049)
Ugandan third versus fourth year pharmacy student knowledge of pharmaceutical care (APS-019)
Use of a Delphi approach to identify skills and qualities essential for international pharmacy practice experiences (APS-038)
Views and perceptions of pharmacy students about online learning and teaching in the COVID-19 era (APS-001)
Virtual course delivery of pharmacy management effect on student pharmacist performance (APS-003)
Virtual exchange and blended mobility: innovative teaching methodologies to foster internationalization at the faculty of pharmacy of university Ceu-San Pablo (Spain) (APS-058)
Virtual global collaborations to empower students to advocate for pharmacy immunizations during COVID-19 and beyond (APS-059)
Clinical biology
An exploratory examination of association of catechol-o-methyltransferase gene variants and neonatal abstinence syndrome outcomes (CBS-006)
Design, identification, optimisation and validation of selective casein kinase II(CK2) modulator (CBS-010)
Fetal transfer of Tadalafil is limited by breast cancer resistant protein in the mouse (CBS-008)
Mediterranean-style diet intervention improves clinical, inflammatory, and mineral profile in pre-diabetes patients (CBS-003)
Multi-drug and extreme-drug resistance in clinical isolates of pseudomonas aeruginosa (CBS-001)
Neutralizing antibodies and anti COVID-19 vaccines. (CBS-005)
The chronomodulatory potential of the therapeutic association of melatonin with Irbesartan, on an experimental model of cardiovascular disease (CBS-004)
The in vitro effects of topical corticosteroids, intranasal saline, and antibiotics on biofilms of staphylococcus spp. Isolated from patients with chronic rhinosinusitis (CBS-002)
The roles of ubiquitin-proteasome system, heat shock protein 70 and regulator of g protein signalling four in morphine-induced behavioural sensitization (CBS-009)
Uncovering anti-infectious properties and radical scavengers of Stenochlaena palustris from Riau province, Indonesia (CBS-007)
Community pharmacy
A decade of integrated collaboration between community pharmacies and primary care in Barcelona, Catalonia, Spain (2012-2022) (CPS-109)
A qualitative exploration of mental health services provided in community pharmacies (CPS-034)
Anaga project: 3 years giving continuity to the treatment of patients living in isolated areas of Tenerife island (CPS-065)
Antibiotic resistance: observation and reflection on the role of community pharmacist in the fight and prevention against antibiotic resistance (CPS-085)
Assessing burnout and anxiety levels in community pharmacists following COVID-19 pandemic: a cross-sectional study in Veneto region, Italy (CPS-012)
Assessment of knowledge and services provided by community pharmacists in Nigeria in managing diabetes mellitus. (CPS-098)
Assessment of the role of the Cypriot community pharmacists during the pandemic (CPS-024)
Attitudes of community pharmacy service users towards vaccination services in community pharmacy (CPS-084)
Attitudes of the general public towards community pharmacy services in Saudi Arabia: a cross-sectional study (CPS-005)
Case study: lean and especially lean daily management (LDM) as a way of improving patient care, well-being of employees at work and efficacy in community pharmacy. (CPS-059)
Changes in collaborative practice between community pharmacists and primary care physicians during the provision of a pharmacist-led medication review with follow- up service (CPS-086)
Characterisation of patient advice in community pharmacy (CPS-019)
Characteristics of the population vaccinated against COVID-19 in community pharmacies (CPS-025)
Cognitive impairment in benzodiazepine users (CPS-002)
Community pharmacists’ experiences and attitudes towards the provision of sexual and reproductive health services: an international survey (CPS-068)
Community pharmacy and primary health care - types of integration (CPS-122)
Community pharmacy perspectives on managing skin conditions: mixed methods online survey (CPS-063)
Community pharmacy staff’s knowledge, educational needs and barriers related to counselling cancer patients and cancer survivors in Denmark (CPS-021)
Community pharmacy-customers’ wishes and attitudes towards COVID-19 antibody tests (CPS-094)
Community pharmacy's assessment of health problems arising from teleworking (CPS-110)
Consumer behaviour related to access and use of online health information and the impact on self-care (CPS-014)
Counselling first hand – understanding the customer and yourself through mentalizing – evaluating an education for pharmacy workforce to support patient centred care. (CPS-082)
COVID-19 rapid antigen testing program in community pharmacies in Catalonia: what is the opinion of pharmacists? (CPS-118)
COVID-19 relation with body mass index (BMI) and nutritional status of elderly people in Bizkaia (CPS-102)
COVID-19 vaccination within Swiss community pharmacies during the COVID-19 pandemic (CPS-054)
Customer education at the pharmacy (CPS-027)
Data driven improvements to clinical estimations of patient adherence - opportunities for future clinical care. (CPS-089)
Delivering person-cantered healthcare via integration of telehealth solutions in an ambulatory care pharmacy setting (CPS-007)
Developing a framework for pharmacist prescribing: a risk-based approach (CPS-097)
Developing a pharmacy COVID-19 vaccination service in Norway (CPS-006)
Development of a training program for community pharmacists as vaccinators in Ghana (CPS-095)
Developments in the field of dispensing of new medicines in Spain (CPS-107)
Digitalisation of supply chain management and logistics systems to improve access to medicines in a community pharmacy practice (CPS-064)
Dispense of hospital-only medicines at the community pharmacies during COVID-19 pandemic: a single-arm, before-and-after study (CPS-080)
Dispensing and counselling diosmin: the role of pharmaceutical intervention (CPS-075)
Drug-related problems and quality of life in patients using psychotropic medicines- case reports (CPS-096)
Education and training in Portuguese pharmacists' response to the COVID-19 pandemic (CPS-051)
Educational strategies in cardiovascular risk patients from the perspective of the community pharmacy (CPS-031)
Electronic medication data transfer program: a multiparty collaboration of 24 healthcare professional associations and organisations (e.g. Pharmacists, prescribers, nurses, patients) in the Netherlands. Presentation type: oral (or poster) (CPS-017)
Evaluation of knowledge about photosensitivity in selective serotonin reuptake inhibitor’s users (CPS-048)
Evaluation of precautionary prescription annulment system in Andalusia from 2014 to 2020. (CPS-100)
Evaluation of treatment adherence of hypertension applying to a community pharmacy (CPS-069)
Facilitators and barriers towards a pharmacist-provided immunisation service: a national cross-sectional study (CPS-061)
Female gender as a conditioning factor of benzodiazepine unsafety during the COVID-19 pandemic. (CPS-003)
Has the pandemic caused an increase in prescription drug abuse? (CPS-115)
HazFarma: three years providing training for professional pharmacy services through Nodofarma Asistencial (CPS-113)
How COVID-19 has changed pharmaceutical prescription in Spain (CPS-037)
Hypothyroidism: the impact of patient awareness on disease management (CPS-076)
Identifying and preventing ENT pathologies in Spanish community pharmacies (CPS-114)
Immunization services in Costa Rica: strengths, challenges and opportunities (CPS-087)
Impact of community pharmacies on access to point-of-care tests for HIV and hepatitis C and B infections: an observational, cross-sectional study (CPS-081)
Impact of the level of autonomy in body mass index (BMI) and nutritional status in elderly people in Bizkaia (CPS-103)
Implementation of a prescription service in Danish community pharmacies: a survey (CPS-047)
Implementation of minor ailments service in a community pharmacy (CPS-112)
Importance of pharmacotherapeutic patient follow-up during the personalised dosage system service (CPS-032)
Influence of pharmaceutical intervention on patients at cardiovascular risk (CPS-033)
Inhacheck. Service for patient training in the correct management and use of inhalers. (CPS-041)
International collaboration with the Swiss association of pharmacists, pharmaSuisse that has led to the implementation in France, in areas where there are few doctors, of a new pharmaceutical triage service called OSYS (orientation in the care system) bas (CPS-083)
Investigating the knowledge and confidence of community pharmacy colleagues dealing with commonly presenting oral health queries in the north east of England. (CPS-015)
Involvement in population management and vaccination service: two new assets in Belgian community pharmacy (CPS-045)
It systems - a timewaster (CPS-058)
Knowledge and application of green practices within community pharmacy (CPS-009)
Knowledge of community pharmacists regarding the use of medications in pregnancy (CPS-036)
Knowledge, attitude and practice of community pharmacists regarding antibiotic use and infectious diseases: a cross-sectional survey in Bulgaria (CPS-010)
Living the skin: a community pharmacy-based follow-up program for acne, atopic dermatitis and hyperpigmentation (CPS-071)
Long COVID-19, a descriptive observational study from Andalusian community pharmacies (CPS-067)
Medicine shortages in Norwegian pharmacies in 2019 and 2022 (CPS-092)
Medicines advertising to community pharmacists during the pandemic (CPS-117)
Mental health training programs for community pharmacists, pharmacy staff and students: a systematic review (CPS-035)
Osteoporosis medication adherence interventions involving pharmacists in primary and secondary care: A scoping review to develop an Initial Programme Theory (CPS-110)
Outcomes of pharmacist-initiated general practitioner referrals for patients with poorly controlled asthma (CPS-090)
Patients' knowledge and attitudes toward multivitamin supplements in Baghdad and Istanbul (CPS-001)
Patients’ satisfaction with e-prescribing (Wasfaty) in Saudi Arabia: a survey of country-level implementation (CPS-004)
Perception of pharmacists towards oral contraception and emergency contraception in Istanbul (CPS-126)
Performance of Portuguese community pharmacies on the provision of professional rapid antigen detection testing for sars-cov-2 (CPS-099)
Personal and occupational changes among community pharmacists during COVID-19 (CPS-013)
Pharmaceutical care program for illiterate patients of La Fé Clinic. Changuinola Bocas del Toro Panamá. March, 2022 (CPS-030)
Pharmaceutical role for COVID-19 and post COVID-19 symptoms. Direct communication and interaction with patients (CPS-043)
Pharmacists are given the authorization for writing prescriptions – is the service known and being used? (CPS-128)
Pharmacists providing sars-cov-2 testing: patients' perception survey (CPS-040)
Pharmacists' views on their role in combating the trade of falsified medicines (CPS-039)
Pharmacists’ engagement in ensuring equity in COVID-19 vaccine awareness and accessibility (CPS-016)
Pharmacogenomics: co-designing a community pharmacy testing service in England (CPS-078)
Pharmacy service challenges during pandemic period (CPS-088)
Plenufar 7. Evaluation of quality of life related to nutritional status. (CPS-111)
Point-of-dispensing e-forms put pharmacists on the map as COVID-era healthcare provider (CPS-023)
Position of community pharmacy with regard to prevention and lifestyle (CPS-029)
POYC – pharmacy of your choice: a paradigm shift towards patient centred pharmaceutical care services in the community (CPS-130)
Precautionary prescription annulment system. Analysis of use according to professionals in the province of Malaga. (CPS-101)
Primary health care transformation: a model of care to improve efficiency and effectiveness and reduce the pressure on Australian emergency departments (CPS-072)
Procedures to optimise the dispense of compounding medications. (CPS-049)
Professional pharmacy competencies for community pharmacy in Spain (CPS-123)
Project “it is in our hearts – pharmaceutical intervention in heart failure” (CPS-125)
Quality indicators report pharmacy system strengthening in federation of Bosnia and Herzegovina (FBIH) in COVID-19 response (CPS-056)
Resilience against COVID-19: rapid antigen test programme in community pharmacies (CPS-066)
Role of pharmacists in improving drug adherence in patients with diabetes (CPS-044)
Safe pharmacotherapy management of breastfeeding woman in community pharmacy- new pharmaceutical care service (CPS-026)
Safety concerns about pharmaceutical compounding practices: the Portuguese community pharmacies’ perspective (CPS-124)
Senna - a project to accelerate the establishment of newly arrived immigrated pharmacists in Sweden (CPS-053)
Services provided by the community pharmacy to fight COVID-19. Two examples in Catalonia (CPS-116)
Social return on investment of pharmaceutical patient consultation (oral presentation) (CPS-018)
Spanish community pharmacies participation during COVID-19 diagnostic tests (CPS-108)
Specialized inquiry service: a response to community pharmacies information needs (CPS-073)
SPISE, a new simple insulin resistance indicator that can be determined in the pharmacy office (CPS-079)
Strengthening medication safety in Danish municipalities – a mapping of challenges (CPS-093)
Substituting medicines responsibly: a multiparty agreement for patients, prescribers, pharmacists and health insurers for substitution of medicines in the Netherlands. (CPS-104)
Sustainable approach for emergencies caused by COVID-19 pandemic in pharmacies in the federation of Bosnia and Herzegovina (FBIH) (CPS-057)
Syringe exchange program in community pharmacies in Catalonia (CPS-119)
Teledermatology with dermoscopy in the pharmacy. (CPS-042)
Telematic medicine sell: review of the service provided by the community pharmacies in Catalonia (CPS-120)
The added value of community pharmacists in a vaccination campaign (CPS-020)
The administration management system for COVID-19 vaccination in Norwegian pharmacies (CPS-008)
The Danish pharmacies in the frontline battling COVID-19: the emergency response, contribution, challenges and lessons learnt during the pandemic. (CPS-055)
The first vaccination by Dutch community pharmacists: the Frisian pilot (CPS-062)
The impact of diabetes mellitus complications on management of disease (CPS-077)
The impact of the COVID-19 pandemic on illegal online pharmacy sales and consumer health risks. (CPS-105)
The national medication safety programme of community pharmacies in Finland (CPS-060)
The national quality improvement program on compounded medicines by the association of pharmacists Belgium: how analytical sciences can promote patients’ health. (CPS-129)
The perceptions and service satisfaction of pharmacists in the community pharmacy. (CPS-127)
The sunflower – a way to successful inclusion of people with hidden disabilities at Glostrup community pharmacy (CPS-052)
The virtual patient - an innovative training tool to improve skills in pharmaceutical care. (CPS-121)
Treatment-seeking behaviour among individuals with uncomplicated sore throat: the important role of pharmacists in reducing primary care burden (CPS-022)
Understanding the barriers and enablers of antimicrobial stewardship experienced by pharmacists when treating upper respiratory tract infections (CPS-091)
Vision 2030 on the role of the family pharmacist in the hospital loop. (CPS-046)
Vision of medical primary care of community pharmacy in Seville (CPS-038)
What barriers do pharmaconomists face, when implementing the medical service of “treatment-pharmacists” prescribe prescriptions? (CPS-028)
What does augmented biology mean to the community pharmacist? (CPS-070)
What would make the patients prefer a medical teleconsultation in a community pharmacy? (CPS-011)
Drug delivery and manufacturing
Additive manufacturing in the era of personalized therapy: a focus on solid dispersion coupled FDM 3d printing (DDD-015)
Biopharmaceutical properties of mucoadhesive powder platform for donepezil nasal delivery (DDD-020)
Development and evaluation of an innovative approach using niosomes based dissolving microneedles to deliver dual antioxidant drugs (DDD-031)
Development of ibuprofen amorphous solid dispersion by hot melt impregnation process using design of experiments approach (DDD-027)
Development of sprayable in situ gelling system for nasal donepezil delivery: preliminary formulation and deposition studies (DDD-022)
Doxorubicin-containing gold nanoparticles-anchored liposomes as delivery carriers: a quality by design strategy to optimize the surface functionalization (DDD-032)
Effect of nanoparticles n‐acetylcysteine (NAC) a thiol antioxidant, in paraquat-induced acute poisoning on lung tissue: an experimental animal study and literature review (DDD-013)
Evaluating mechanical properties of paroxetine-loaded filaments to enable printability by fused deposition modelling (DDD-009)
Evaluation of nanocarriers for the encapsulation and antimicrobial activity enhancement of Origanum vulgare subsp. hirtum extract (DDD-019)
Evaluation of the type and frequency of extemporaneous formulations dispensed in hospital and community pharmacies in Ireland (DDD-024)
Extraction procedure of an extract rich in flavonoids from Murta (Ugni molinae) and its nanoencapsulation in chitosan-tripolyphosphate (DDD-011)
Flow cytometry as an analytical method of drug-induced apoptosis in 3D bioprinted melanoma cells (DDD-006)
Formulation design and characterization of transungal patches enabled by Itraconazole nanosponges for targeting onychomycosis: a strategical approach for antifungal drug resistance (DDD-008)
Green synthesized plant based zinc oxide nanoparticles: therapeutic prospective for anticancer activity (DDD-004)
Haloperidol loaded NLC: formulation, characterization and stability evaluation (DDD-028)
Harnessing artificial intelligence for drug carrier systems development (DDD-003)
Impact of viscosity and pH of dissolution medium on ethanol-induced dose dumping from sodium alginate matrix tablets (DDD-001)
Intestinal absorption of the prodrug Olmesartan Medoxomil is enhanced by oatp2b1-mediated uptake (DDD-010)
Investigation of nanoparticulate platforms for transdermal delivery of Tolvaptan (DDD-018)
Novelty of quantum dots as a drug delivery vehicle design for nanoparticle (DDD-014)
Peptide hydrogels as a long-acting injectable drug delivery platform for HIV/Aids (DDD-016)
Physicochemical stability of allopurinol, amitriptyline hydrochloride, amlodipine besylate, clindamycin hydrochloride, hydrocortisone, metronidazole, naltrexone hydrochloride, spironolactone, trimethoprim with sulfadiazine, and ursodiol extemporaneously c (DDD-023)
Plasma-mediated covalent bonding of rhamnolipids onto PDMS surface as a strategy to overcome vascular catheter-related infections (DDD-025)
Print parameter optimisation for three-dimensional bioprinting of hydrogel scaffolds (DDD-007)
Release profiles and in vivo bioavailability in beagle dogs of Rebamipide nanosuspension-loaded bilayer tablet (DDD-017)
Simple, green and one – pot strategy for synthesis of calcium orotate (DDD-012)
Study of the effect of chitosan-glutathione nanoparticles on the redox state of breast cancer cells. (DDD-005)
The emergent need for novel antimicrobial strategies: can biosurfactants play that role? (DDD-026)
The feasibility study of nanoparticles derived from Glycyrrhizae radix as a vaccine adjuvant for cancer immunotherapy (DDD-029)
Using sophorolipids for the prevention of microbial contamination on silicone-based medical devices (DDD-002)
What will it take to meet Africa’s vaccines needs? (DDD-021)
Health and medicines information
A new self-report tool for the extent to which consumers follow directions (FDs) for non-prescription medicines (NPMs) provided on packaging or advice from healthcare professionals - the FD-NPM scale. (HMI-005)
A study on effect of steroids on acute inflammatory markers in COVID-19 patients (HMI-007)
A study on the incidence of cisplatin-induced nephrotoxicity in the adult population (HMI-027)
A systematic approach to scrutinizing noises in medical literature (HMI-018)
A systematic review and thematic synthesis: exploring health information exchange between community pharmacists and patients with atopic dermatitis (HMI-006)
Accessibility to community pharmacy in Indonesia: a community pharmacy density mapping using geographical information system (HMI-010)
An update on anti-cholinergic burden for pharmacy researchers and practitioners (HMI-030)
Benefits of IDMP for medicinal product dictionaries (HMI-012)
BOT PLUS 2022 – new feature (HMI-050)
BOT PLUS lite: accessible information on medicines (HMI-051)
Challenges of the new EU clinical trial regulation EU 536/2014 (HMI-028)
Challenging in maintaining CPDs during COVID-19 pandemic: the Indonesian pharmacists’ association experience (HMI-043)
Concise medicine information improves health literacy and therapy compliance among patients with low health literacy (HMI-046)
COVID-19 setback in the rationalization of pharmacotherapy (HMI-027)
COVID-19 vaccine data collection, analysis, and visualization to support informed decision making in Africa (HMI-035)
COVID-19 vaccine hesitancy among Ethiopian healthcare workers (HMI-011)
Detection and evaluation of vaccine fake news from Romanian tweets (HMI-045)
Development of a web-based application for the improvement of population health habits against sars-cov-2 (HMI-039)
Drug-drug interaction alerts and clinical relevance: pharmacokinetics and risk analysis (HMI-037)
Educational outreach visits as a strategy to increase knowledge of essential medicines lists (HMI-029)
Electronic medicines management systems and medicines administration errors: a qualitative thematic analysis (HMI-029)
Food-medication interaction: writing a treatise (HMI-047)
General pharmaceutical council of Spain’s response against COVID-19 (HMI-052)
Guidelines for ailments treatable by over-the-counter medication. (HMI-002)
Health education during pandemic: an online intervention about the responsible use of medicines in older people. (HMI-040)
Health information communication technology evaluation frameworks for pharmacist prescribing (HMI-034)
Hormonal and non-hormonal contraceptives: education for patients through a virtual platform (HMI-014)
Impact of COVID-19 pandemic on consumers' access to essential medicines in Nigeria. (HMI-053)
Implementation of ISO 27001 -2013 on the pharmacist information system (SIAp) application to ensure compliance with personal data security requirements (HMI-041)
Improving oral drug administration in patients with swallowing problems and feeding tubes (HMI-004)
Influence of the pandemic situation caused by COVID-19 on the dispensing of multi-compartment compliance aids in Bizkaia. (HMI-036)
Information provision about medicinal cannabis in the Netherlands (HMI-016)
International expansion of the vaccination champion project to promote vaccination confidence and address vaccine hesitancy (HMI-003)
MEDICAMENTO ACCESIBLE plus: a tool at the patient's disposal (HMI-048)
Medication refill adherence amongst patients in the central chronic medicines dispensing and distribution programme in two districts of KwaZulu-Natal, South Africa, prior to and during the COVID-19 pandemic (HMI-044)
National drug formulary: a Singapore-specific, authoritative and national reference base (HMI-022)
Paper or electronic drug information leaflet (HMI-020)
Pharmacist information system (SIAp): it is cursed or a blessing in disguise during a pandemic. (HMI-017)
Pharmacists’ perspectives about asthma treatment in primary care centres in Kuwait (HMI-042)
Pharmacotherapeutic innovation is keeping pace during COVID-19 pandemic (HMI-049)
Piloting medication management resources for caregivers, patients, and volunteers in Singapore (HMI-019)
Portuguese index of access to hospital medicines 2021 – an improved indicator (HMI-001)
Review of terminology managements tools used in pharmaceutical translations (HMI-032)
Role of Mirabegron and Carvedilol in treatment of ulcerative colitis (HMI-009)
Safety assessment decision support for excipients in medicinal products (HMI-015)
Sarilumab-associated neutropenia and thrombocytopenia in patients with rheumatic diseases (HMI-025)
Sentinel pharmacy network of Catalonia: what knowledge do women have about the Isotretinoin teratogenic effects? (HMI-026)
Teaching pharmacy students how to support patients who struggle swallowing solid oral dosage forms (SODFs) (HMI-021)
The appropriateness of secondary medicine packaging for people with visual impairment (HMI-008)
The importance of the use of biosimilars in practice, advantages and disadvantages (HMI-028)
The information that direct healthcare professional communications offer us (HMI-031)
The need for global identification of medicinal products (HMI-013)
The pharmacist information system (SIAp) breaks the distance and time boundaries in Indonesian pharmacist services (HMI-033)
Training talks’ impact in the sustainability project of rural and VEC pharmacy as a basis for the improvement of life and depopulation in rural environment (HMI-023)
Treating huntingtin's disease using CRISPR/Cas9 gene editing: designing multiple sgRNA using in-silico tools (HMI-038)
Xarxa patients: educating in self-care and empowerment of patients (HMI-024)
Hospital pharmacy
A case of central nervous system adverse reactions caused by using scopolamine injection to soften the cervix for vaginal delivery (HPS-051)
A hospital pharmacy climate change stewardship strategic framework - key early outcomes (HPS-076)
A multi-modal approach to inter-professional training program for postgraduate pharmacists (HPS-043)
A pharmacist led intervention to reduce the number of antibiotic missed doses in the paediatric ward of a tertiary hospital Nigeria. (HPS-029)
A study on the assessment of clinical outcomes and factors related to the severity of diabetic foot ulcer (HPS-030)
A tool for hospital pharmacist interventions optimization (HPS-074)
A vital approach in the fight to slow antimicrobial resistance: partnership between the pharmaceutical forum of the Americas and the society of infectious diseases pharmacists to support antimicrobial stewardship education for pharmacists in Latin America (HPS-077)
Addressing mixed infections with customized 3d-scaffolds (HPS-009)
An evaluation of adherence to insulin therapy in diabetic patients attending diabetic clinic of Lagos state university teaching hospital Lagos Nigeria (HPS-070)
Analysis of antibiotic consumption in an intensive care unit (HPS-013)
Analysis of anticholinergic burden and influencing factors in elderly patients (HPS-081)
Analysis of medication error reporting at St. Bartholomew hospital in London, England (HPS-078)
Analysis of the effect for importing the concept of entrustable professional activities (EPAs) into the education and training of pharmacists in a medical centre in Taiwan (HPS-044)
Antibiogram of clinical isolates from primary and secondary healthcare facilities: a step towards antimicrobial stewardship (HPS-003)
Antimicrobial stewardship and infection prevention and control programs across three healthcare levels: a qualitative study (HPS-002)
Assessment of patient satisfaction with pharmaceutical services in two tertiary health facilities in rivers state, Nigeria. (HPS-056)
Benralizumab effectiveness in patients with severe eosinophilic asthma. (HPS-091)
Cancer outpatient treatment analytics and data visualization through business intelligence (HPS-087)
Care continuity hospital pharmacy – community pharmacy in patients with solid organ transplantation (HPS-102)
Chronic pharmacology review circuit for hospitalized polymedicated patients and conciliation at discharge (HPS-060)
Clinical outcomes of teriflunomide and polypharmacy in relapsing multiple sclerosis: a retrospective case-series (HPS-049)
Clinical pharmacy interventions and antimicrobial therapy in a rural hospital in Austria (HPS-041)
Comparing adverse drug reactions on TB regimens: a case study in KZN, South Africa (HPS-059)
Comparison of patient-associated risk factors between acquisition of Klebsiella pneumoniae and Escherichia coli (HPS-096)
Compliance in clinical trials, the oncology patient experience (HPS-062)
Cost analysis of new antibiotics against serious gram - infections used in intensive care units: cefiderocol vs meropenem/varbobactam (HPS-026)
Creating policies for the compassionate use of medical cannabis in healthcare facilities (HPS-036)
Deep learning application to automatic classification of pharmaceutical interventions: towards a better monitoring of pharmaceutical analysis (HPS-005)
Design of a structured objective clinical assessment test for students in practices in the pharmacy service (HPS-061)
Developing total parenteral nutrition app learning platform improves the work efficacy and efficiency of TPN (HPS-021)
Development of a strategic plan for a hospital pharmacy department (HPS-031)
Development of hospital pharmacy services at transition of care points: a scoping review (HPS-083)
Discuss the changing of incidence in dispensing errors after setting up automatic dispensing equipment (HPS-099)
Effectiveness and safety of mepolizumab in the treatment of severe eosinophilic asthma (HPS-092)
Effectiveness and safety of nab-paclitaxel in metastatic breast cancer (HPS-014)
Effectiveness of pharmacist clinic in a medical centre in Taiwan (HPS-018)
Evaluating the feasibility and learning performance of objective structured clinical examination (OSCE) training scenarios effectively (HPS-045)
Evaluation of hospital-based medicine information aimed for primary health care professionals (HPS-025)
Evaluation of inpatients medication prescribing practice at Ibrahim Malik teaching hospital: a descriptive cross-sectional study (HPS-032)
Evaluation of therapeutic effects of SGLT2 inhibitors in type 2 diabetes mellitus patients: a single centre, case series study (HPS-024)
Experience of patisiran optimization building healthcare team (HPS-038)
Experience of trifluridine/tipiracil and regorafenib in metastatic colorectal cancer. (HPS-066)
Exploration and practice of doctor-pharmacist cooperation in antimicrobial therapy for gynaecologic oncology patients after surgery (HPS-094)
Explore the patterns of resistance mutations to antiretroviral drugs in treated patients infected with HIV in Northern Oman. Type of presentation will be a poster presentation (HPS-004)
FARMATEC innovation training project (HPS-088)
Gemcitabine monotherapy for advanced mycosis fungoides (HPS-067)
Givosiran and hereditary coproporphyria: case report (HPS-065)
Glycemic control and treatment with isglt2 drugs in type 2 diabetic patients in an urban population attended at a primary care centre (HPS-011)
Guselkumab in moderate-severe psoriasis: effectiveness assessment (HPS-093)
Impact of a comprehensive intervention bundle implementing drug burden index as a clinical risk assessment tool on deprescribing anticholinergic and sedative drugs in older adults admitted to an Australian acute hospital: a pilot study (HPS-037)
Impact of a standardized patient-controlled analgesia (PCA) order form on adverse drug events in opioid-naive post-operative patients (HPS-072)
Impact of anti-inflammatory enriched enteral formula in critical patients infected with sars-cov-2 (HPS-064)
Impact of COVID-19 on the clinical and angiographic profile in patients with coronary artery disease (HPS-079)
Impact of education of paediatric caregivers on knowledge and use of antibiotics (HPS-001)
Impact on the optimization of treatment and the clinic of inflammatory bowel disease through pharmaceutical monitoring (HPS-089)
Implementing pharmacists and medicines management technicians in a remote pre-assessment service at a large tertiary centre: a quality improvement project (HPS-054)
Improving the efficiency of stocktaking via smart phone in southern Taiwan regional hospital pharmacy (HPS-046)
Initial implementation and evaluation of an intervention to improve the review of antibiotics in Scottish acute care hospitals (HPS-055)
Integrated multidisciplinary care pathway for optimising secondary prevention lipid modification therapy in people with established cardiovascular disease - six-month interim analysis (HPS-103)
Intralesional methotrexate for keratoacanthoma of the face (HPS-068)
Management measures of supply shortages of immunoglobulins among hospitals in Catalonia (HPS-040)
Medication reconciliation in stage 5 chronic kidney disease patients. (HPS-048)
Nursing home residents’ attitudes towards deprescribing: a Danish survey (HPS-082)
Optimizing medication administration safety by improving compliance with barcode medication administration at Johns Hopkins Aramco (HPS-006)
Participation of a pharmacist in the multidisciplinary care team for a long -term inpatient to ensure patient safety indirectly contributes to the improvement of his quality of life (QOL) (HPS-028)
Patient counselling at outpatient pharmacy department: patients’ perspective (HPS-080)
Patient satisfaction with pharmaceutical care service on self-injecting glucagon-like peptide-1 receptor agonists (HPS-022)
Patients satisfaction with pharmaceutical care activities in a hospital ward setting (HPS-058)
Pharmaceutical contribution to the prevention of levodopa-food interactions (HPS-033)
Pharmaceutical experience - sars-cov-2 pandemic- Dr Rafael Hernández hospital pharmacy, Caja de Seguro social, 2021 Panamá. (HPS-039)
Pharmacist medication education in-patient with acute myocardial infarction (HPS-016)
Pharmacist-led multidisciplinary approach in preventing strokes in people with atrial fibrillation (HPS-094)
Pharmacist-led multidisciplinary approach in preventing strokes in people with atrial fibrillation (HPS-094)
Pharmacotherapeutic interventions in hemato-oncology patients and palliative care. Hospital Dr Rafael Hernández, Caja de Seguro Social. January to April 2022 (HPS-027)
Predictors of mortality in patients with Lassa fever in federal medical centre Owo - a tertiary health institution in Nigeria (HPS-057)
Prevalence and predictors of opioid use before orthopaedic surgery in an Australian setting: a multicentre, cross-sectional, observational study. (HPS-053)
Preventing medication errors for better care by using bedside technology (HPS-075)
Real-world data for oral cladribine in relapsing multiple sclerosis (HPS-069)
Reducing near-miss of infusion rate error with information technologies of CPOE and CDSS in the inpatient department in Taiwan (HPS-019)
Review of home medication of hospitalized polymedicated patients: deprescription (HPS-090)
Risk factor for patient acquisition of carbapenem-resistant pseudomonas aeruginosa (HPS-098)
Role of pharmacy professionals in preventing dose-related errors (HPS-086)
Role of the pharmacist in the care of the lung transplant patient (HPS-063)
Secukinumab for the treatment of plaque psoriasis and psoriatic arthritis (HPS-012)
Severe neutropenia in African-descent patients treated with clozapine: results of a six-month, multinational open-label clinical trial (HPS-071)
Severity of medication administration errors in a teaching hospital in Brazil (HPS-007)
Small bowel and spleen infarction in the patient with tense bullous pemphigoid over right face and neck (HPS-085)
Streamlining pharmacy discharge processes for COVID-19 patients in a paediatric hospital. (HPS-023)
Strengthening antimicrobial stewardship capacity of healthcare workers using a hub and spoke model: - a pilot at two public tertiary hospitals in Zambia (HPS-008)
Study of in-hospital protein drug supply chain (HPS-101)
The analysis the medication that children may spit most (HPS-097)
The Dos and Don’ts of administrating COVID-19 vaccine to children aged 5-11. (HPS-104)
The evaluation of the therapeutic effects of low dose edoxaban in atrial fibrillation patients: a single centre, case series study (HPS-100)
The experience of sublingual using of atropine eye drops in the treatment of clozapine‐induced sialorrhea (HPS-052)
The medicine information helpline - a patient safety initiative established by the hospital pharmacy in the capital region of Denmark (HPS-034)
The remuneration of professional services delivered by clinical pharmacists in intensive care units in Taiwan (HPS-017)
The trend of carbapenem utilization in community-onset urinary tract infections in hospitalization and the risk factor analysis for mortality: a study using the Taiwan national health insurance research database from 1997 to 2012 (HPS-050)
Total phenolic content and antioxidant capacity of pomace from Cabernet Sauvignon (HPS-010)
Use of a standardized patient-controlled analgesia (PCA) order form in opioid-naive patients with oral mucositis (HPS-073)
Using modified CPOE system to reduce intravenous medication errors in Taiwan academic medical centre (HPS-020)
Using PDCA management methods to effectively improve the overall quality of drug dispensing and shorten the waiting time of patients (HPS-042)
Utilizing a quality control cycle to improve the satisfaction of patients receiving pharmaceutical service in the outpatient pharmacy: taking one regional teaching hospital as an example (HPS-095)
Utilizing rubric to improve quality of formative feedback for pre-registration pharmacists’ journal club presentations (HPS-047)
Validated stability studies for 40 paediatric extemporaneously compounded oral solutions and suspensions (Suspendit): acetazolamide, amphotericin b, atenolol, baclofen, budesonide, buspirone, captopril, clonazepam, dipyridamole, fluconazole, fluoxetine, g (HPS-015)
Validating the ‘student-obtained medication histories’ program: the accuracy of pharmacy students compared to pharmacists (HPS-035)
Industrial pharmacy
Cannabinoids vs. Terpenes quantification in cannabis flower HPLC-UV and GC-FID. (IPS-007)
Cleaning Validation Strategy in Cannabis facilities – A Cannabinoid PDE Limit Approach (IPS-006)
Development of o/w creams stabilized with an alkylpolyglucoside non-ionic emulsifier containing Cinnamomum zeylanicum bark extract or Cotinus coggygria extract (IPS-003)
Investigation of the interest and views of Nigerian pharmacy undergraduates towards a career in industrial pharmacy (IPS-002)
Pharmacokinetic study of temoporfin-loaded invasomes after their in vivo topical application onto mice bearing subcutaneously implanted ht29 tumour (IPS-004)
Quality by design (QbD) in pharmaceutical industry (IPS-001)
Sample size used in bioequivalence studies around the world (IPS-005)
Military and emergency pharmacy
International medical relief activities by pharmacists during the COVID-19 pandemic (MEP-002)
Management of the COVID-19 health crisis: a survey in Swiss hospital pharmacies (MEP-003)
Management of the COVID-19 health crisis: a survey of Swiss Health authorities’ response (MEP-004)
The sustaining of virtual missions’ partnerships with pharmacists without borders Canada during the COVID-19 pandemic (MEP-001)
New generation of pharmaceutical scientists
All aboard - a cross-sectional study to characterize the population of young Portuguese pharmacists working abroad (NGP-002)
Pharmacy education, early career progression, and professional identity formation in the face of the COVID-19 pandemic; a qualitative assessment of perspectives (NGP-001)
White book – the vision of young Portuguese pharmacists for the decade (NGP-003)
New medicines
A comparative study on four Egyptian allium species: in vitro antioxidant, total phenolic, and flavonoid content. (NMS-011)
A computational approach of structure-based virtual screening towards the discovery of selective 5α-reductase type ii inhibitors for BPH treatment (NMS-027)
An alternative approach to circumvent low aqueous solubility for a BCS class ii compound using lipid-based suspensions (NMS-009)
Bioassay guided fractionation of endophytic Penicillium chrysogenum isolated from Sinularia spp. (NMS-030)
Cannabidiol: knowledge and perceptions of society (NMS-005)
Characterization and purification of antimicrobial biosurfactants towards their individual usage on pharmaceutical applications (NMS-028)
Characterization, antibacterial and antioxidant potentialities of encapsulated biogenic silver nanoparticles utilizing Gracilaria corticata extract (NMS-018)
Correlation between phenolic composition of three varieties of Egyptian date seeds (Phoenix dactylifera l.) and their antidiabetic activity (NMS-017)
Direct n1-selective alkylation of hydantoins using potassium bases (NMS-020)
Effect of nanoparticles n‐acetylcysteine (NAC) a thiol antioxidant, in paraquat-induced acute poisoning on lung tissue: an experimental animal study and literature review (NMS-013)
Evaluation of the neuroprotective potential of ibogaine in an in vitro neurodegeneration model for Alzheimer’s disease (NMS-029)
Folate receptor-targeted plasmonic nanoparticle of a thiazolidinedione derivative exerted significant chemo-photothermal effect on in vivo-breast cancer model (NMS-026)
Identification of novel compounds targeting the mu-, kappa- and delta-opioid receptors (NMS-010)
In vitro activity and antioxidant investigation of fruit wines (NMS-003)
In vitro plant cell culture as a source for production of pentacyclic triterpenes acids from the roots of a Colombian native plant for management of prediabetic state (NMS-033)
Influence of different treatment of Vožd cultivar on total phenolic content and antioxidant capacity of wine (NMS-004)
Ketoconazole and verapamil cause the reduction of heme (NMS-019)
Maqui [Aristotelia chilensis (Molina) Stuntz] anthocyanin concentrates as a potential nutraceutical (NMS-012)
Mebendazole in paediatric patients with giardiasis: a systematic review and meta-analysis of randomized controlled trials (NMS-036)
Medicinal cannabis uses in rare diseases (NMS-025)
Methanol extracts and volatiles of Telekia speciosa (Schreb.) Baumg. (NMS-008)
Microglial NMDA receptors and mitochondria- derived superoxide mediate aβ1-42 oligomer-induced neurotoxicity in primary rat brain cultures (NMS-023)
Molecular docking and molecular dynamic study of some flavonoid and terpenoid compounds for Alzheimer therapy (NMS-024)
Molecular docking and molecular dynamics simulations studies of some selected Punica granatum l. As inhibitors of RNA-dependent RNA polymerase activity (nsp12) of sars-cov-2, a key drug target for COVID-19 (NMS-014)
Pre-clinical study of a dietary supplement prototype of pentacyclic triterpenes obtained from Cecropia angustifolia roots as a modulator of type 2 diabetes (NMS-021)
Prediction and introduction of novel selective cox-2 as anti-inflammatory and anti-cancer agents using structure-based viral screening and molecular dynamics stimulation (NMS-031)
Rapid quantitative estimation of siponimod in rat plasma by liquid chromatography- tandam mass spectroscopy and its application to pharmacokinetic studies (NMS-032)
Rational design of heat shock protein (hsp-70) inhibitors (NMS-035)
Reflections on the use of cannabidiol for medicinal purposes and the views of healthcare professionals (NMS-006)
Relaxing effects of novel benzodiazepine-like ligand mp-iii-058 on rat trachea (NMS-015)
Remedsevir loaded nanoparticles as potential treatment for COVID-19 (NMS-022)
Small extracellular vesicles derived from adipose tissue mesenchymal stem cells: possible new therapy against osteoarthritis (NMS-034)
The potential of ayahuasca-assisted meditation to improve social cognition (NMS-016)
Personalised and precision medicine
Adherence and adverse drug reactions in metastatic breast cancer patients treated with CDK 4/6 inhibitors (PPM-001)
Factors affecting clopidogrel safety in the montenegrin population (PPM-004)
Role of clinical pharmacist - enhancing patient experience with precision medicine (PPM-003)
Venous thromboembolism risk in patients with hormone receptor‑positive her2‑negative metastatic breast cancer treated with CDK 4/6 inhibitors (PPM-002)
Pharmacy practice research
A comparative evaluation of intraperitoneal instillation of combination of bupivacaine with tramadol or dexamethasone in laproscopic surgeries (PPR-019)
A qualitative exploration of key stakeholders’ views and perceptions in relation to organisational change for the implementation of polypharmacy management in Oman (PPR-007)
A systematic review and thematic synthesis to identify factors that influence pharmacists’ involvement in asthma care services: an identity crisis. (PPR-052)
An assessment of perceived depression in patients in Pune, India (PPR-010)
Analysis of pharmacists' interventions on paediatric outpatient prescriptions in South Batinah governorate, Oman. (PPR-005)
Antimicrobial stewardship tools developed through the commonwealth partnerships for antimicrobial stewardship (CwPAMS) health partnership scheme. (PPR-059)
Assessing the Quality of life in HIV-infected patients receiving a fixed dose combination therapy at a public primary healthcare (PPR-068)
Assessment of barriers to optimum enteral nutrition practices as perceived by critical care providers (PPR-023)
Assessment of compliance of neonatal intensive care unit nurses with standard precautions of infection control: a clinical pharmacist contribution (PPR-002)
Assessment of hepatitis c virus-human immunodeficiency virus co-infection among human immunodeficiency virus patients on anti-retroviral therapy at public secondary care hospitals in a north-central senatorial district, Nigeria (PPR-057)
Assurance of quality health education and coverage amongst adolescents in the republic of Benin (PPR-013)
Attitudes of pharmacists about anthocyanin-based products from blueberry fruit in the pharmacies (PPR-027)
Breaking inertia in addressing older people’s drug iatrogenia in Catalonia: emerging barriers and enablers with pharmacists and other health professionals' perspectives (PPR-064)
Burnout syndrome in pharmaceutical sector employees in the republic of Serbia and the republic of Srpska (PPR-037)
Can a course in narrative medicine encourage empathy in pharmacists’ medication counselling? – a before/after intervention study using the Jefferson scale of empathy (PPR-029)
Can pharmacists improve their patient communication by reading fiction? Narrative medicine in pharmacy practice – a feasibility study (PPR-030)
Care homes independent pharmacist prescriber study (CHIPPS): cluster randomised controlled trial to estimate effectiveness, cost-effectiveness and safety. (PPR-058)
Chagas disease screening program in community pharmacies from Barcelona, Catalonia, Spain (PPR-036)
Chief pharmaceutical officer’s global health (CPhOGH) fellowship scheme: assessing the benefits of commonwealth partnerships for antimicrobial stewardship (CwPAMS) collaborative projects (PPR-025)
Collaboration agreements between community pharmacies and primary healthcare centres for acute COVID-19 and long-term COVID-19 management in the northern metropolitan area of Barcelona, Catalonia, Spain. (PPR-034)
Community pharmacy provider and client experiences with COVID-19 rapid antigen testing in Kenya (PPR-039)
Community-dwelling mental health patients access to pharmacogenetics through community pharmacies as a tool for pharmacotherapeutic optimization: a research design in Barcelona, Catalonia, Spain. (PPR-035)
Customer satisfaction with online dispensing and counselling services of a community pharmacy: a case study with the university pharmacy online services in Finland (PPR-040)
Effects of medical cannabis on illness severity, depression and anxiety in fibromyalgia patients: a large retrospective case series (PPR-056)
Efficacy and safety of panitumumab in adenocarcinoma of the colon and rectum (PPR-063)
Encouraging advocacy by Portuguese pharmacists: preliminary results on the development and implementation of a programme (PPR-046)
Evidence-based practice and it’s perceived barriers among hospital pharmacists: a survey in a resource-limited setting (PPR-009)
Exploring the experience of young people about pharmacy services in primary care: a cross-sectional study (PPR-033)
Factors associated with medicines related problems (MRPs) in frail older people from primary care-a mixed methods study (PPR-055)
Gender differentiation in pharmaceutical intervention during the COVID-19 pandemic with benzodiazepines: expectation versus reality? (PPR-006)
Generics adoption in Lebanon: a response to the Lebanese economic, social and, political crisis (PPR-022)
Healthcare professionals’ knowledge and implementation of valproate related safety communications in Kuwait (PPR-008)
Hypertension management. The 22-year history of Mr. Jonas (PPR-054)
Hypertensive disorders amongst pregnant women seeking care at health facilities in the Ashanti region in Ghana (PPR-012)
Impact on clinical outcomes of the integration of a virtual clinical pharmacist in a primary care practice (PPR-004)
Indirect costs of haemodialysis versus peritoneal dialysis from a patient’s perspective for the management of end stage renal disease at a tertiary hospital in Gauteng (PPR-042)
Indonesian young pharmacists group’s “local heroes”: a project to unveil pharmacist contribution nationally (PPR-051)
Introduction and results analysis of international pharmaceutical submission tutoring course at Taipei pharmacists’ association (PPR-016)
Involvement of patients' organisations: key approach to improve pharmacists' empowerment in pharmaceutical care (PPR-047)
Knowledge, attitudes, and perceptions of a patient population on the COVID-19 vaccine rollout in South Africa. (PPR-050)
Maximizing pharmacists’ roles using collaborative pharmacy practice agreement and provider status in the us (PPR-015)
Oncology clinical trial patient satisfaction with pharmacy service in a third level hospital (PPR-062)
P-glycoprotein neurotransmitters homeostasis modulation following the administration of CNS active drugs (PPR-021)
Paediatric oral extemporaneous preparations and practices: FIP paediatric formulation focus group (PFFG) global survey (PPR-014)
Patient perceptions towards biosimilars and switching of biologics: a patient survey (PPR-041)
Perception of health professionals on drug iatrogenia and its prevention: a transpyrenean approach (PPR-065)
Perceptions of healthcare professionals of healthcare services provided virtually in Kuwait: a qualitative study (PPR-001)
Pharmacovigilance of medicines used in the treatment of chronic pain (PPR-067)
Pharmacy staff’s ability to be emotionally aware – does it affect the quality of pharmacy counselling? (PPR-061)
Population-based pharmacy care services in a private practice physician group in the united states (PPR-017)
Real-world effectiveness in hypertension and hyperlipidaemia collaborative management between pharmacies and primary care in Portugal: a multicentre quasi-experimental pragmatic controlled trial (USFarmácia®) (PPR-018)
Response to the coronavirus disease 2019 (COVID-19) pandemic at private community pharmacies in Kenya (PPR-048)
Rising blood pressure amongst patients in Pune, India: a role for clinical pharmacists (PPR-011)
Systematic review and meta-synthesis - challenges and problems during professional development of pharmacists and preceptors (PPR-028)
The assessment of pharmaceutical care on patient safety, drug-treatment effectiveness and quality of life in conditions related to the use of psychotropic medicines-pilot study (PPR-053)
The direct costs of treating and managing haematological cancers from the perspective of a tertiary hospital, in South Africa (PPR-043)
The effect of itoride compared with metoclopramide on adequacy of enteral nutrition in critically ill patients with enteral feeding intolerance (PPR-024)
The effect of statin types on the quality of life of patients with heart failure (PPR-049)
The impact of cross-border e-prescriptions on access and safe use of medications - a survey of pharmacists in Finland and Estonia (PPR-038)
The pharmacists’ role in screening patients experiencing homelessness for HIV and hepatitis c (PPR-044)
The smart pharmacist podcast: medication safety learning anywhere anytime (PPR-031)
The use of local data to develop and implement sustainable antimicrobial stewardship (AMS) interventions as part of the commonwealth partnerships for antimicrobial stewardship scheme (CwPAMS). (PPR-060)
Utilizing the patient activation measure (pam) as part of comprehensive medication review services for complex, high-risk patients. (PPR-045)
What challenges are we facing regarding medication complexities among elderly patients with dementia in nursing homes? A Portuguese cross-sectional study (PPR-003)
Which pharmacist interventions improve hypertension control? A systematic review and meta-analysis of randomised controlled trials (PPR-026)
Pharmacy technicians
A shot in the arm: the evidence and gaps regarding the role of pharmacy technicians in vaccination services (TEC-004)
Interprofessional education and collaboration between pharmacy technician students and university college Copenhagen students (TEC-001)
Pharmacy technician workforce development in primary care roles (TEC-002)
Stay engaged! The pharmacy technicians' workgroup in a paediatric hospital (TEC-003)
Regulatory sciences and quality
A comparison of European and Japanese pharmaceutical regulations: drug information and over the counter products perspective (RSC-012)
Active safety monitoring of the mRNA Pfizer-Biontech (Comirnaty) vaccine using a recipient survey: a New Zealand first. (RSC-004)
An overview of biosimilars approval in brazil (RSC-008)
Availability and quality assessment of different brands of artemisinin-based combination therapy (act) tablets circulating in Kaduna state, Nigeria (RSC-007)
Enhanced post-marketing surveillance of the COVID-19 vaccines in aotearoa New Zealand. (RSC-005)
Ensuring equitable access to medicines, vaccines and supplies through a health systems approach: recommendations from the commonwealth civil society policy forum 2021 (RSC-017)
Exploring Mongolian healthcare professionals’ experience adverse drug reaction reporting: part of a questionnaire survey (RSC-016)
Facilitating access to medicines in Latin America (RSC-002)
Good laboratory practice in a research clinical analysis laboratory (RSC-014)
Investigation of methanol impurities in commercial and formulated hand sanitizers using GC. (RSC-001)
Managing bridging data for regulatory purposes (RSC-006)
Pharmaceutical regulation, policy and access to medicines in the European Union. (RSC-015)
Quality of liquid measuring devices enclosed with paediatric oral liquid dosage forms in Sri Lanka (RSC-009)
Quality systems of pharmacy services of a research centre (RSC-013)
The quantity of anthocyanins in blueberry fruit based dietary products and juices (RSC-003)
Weak regulations threaten the safety of consumers of harmful weight-loss supplements (WLS) globally: results from a pilot global policy scan of weight-loss supplement regulation (RSC-010)
Social and administrative pharmacy
10 years of the apothecaries project: the development agent pharmacist (SAP-027)
A scoping review of the minority stress processes experienced by sexual and gender minority patients in pharmacy settings: implications for healthcare avoidance (SAP-059)
Abem: programme (Solidary Medicine Network) - social impact assessment (SAP-046)
Antimicrobial utilization in outpatient upper respiratory tract infections throughout the us, 2019-2021 (SAP-042)
Assistance to la Palma: the official pharmaceutical society of Santa Cruz de Tenerife collaborating with the institutions to deal with losses generated by the eruption of the volcano (SAP-019)
Awareness of occupational exposure to hazardous substances and medicines in the pharmacy (SAP-041)
Barriers for recruitment and retention in the diabetes prevention program (DPP) in a medically underserved area (SAP-014)
Behavioural determinants influencing pharmacy professional's decisions to join and maintain membership in professional associations (SAP-061)
Capacity building programme on pharmacy law and ethics: development and preliminary evaluation of an on-line curriculum for Portuguese community pharmacists (SAP-037)
Challenges in the integration of clinical pharmacy practice in patient care in Ghana (SAP-005)
Communication of pharmacists’ roles and services during the COVID-19 pandemic: a content analysis of Canadian pharmacy organizations (SAP-053)
Community pharmacists’ recommendation of complementary medicines to their customers: a systematic review (SAP-055)
Cost analysis, cost-effectiveness, and cost-utility of hypertension and hyperlipidaemia collaborative management between pharmacies and primary care in Portugal alongside a trial compared with usual care (USFarmácia®) (SAP-012)
Cost-effectiveness analysis of atezolizumab plus bevacizumab versus sorafenib in first-line treatment for Chinese population with unresectable hepatocellular carcinoma in Taiwan (SAP-057)
Council of Europe ‘resolution on the implementation of pharmaceutical care’ - a step forward in the promotion of appropriate use of medicines and patient-centred care (SAP-047)
Council of Europe’s guidelines to harmonize the medication review process in Europe (SAP-048)
Development and evaluation of a holistic university weight loss program (SAP-015)
Development and evaluation of an online pocket guide to quality improvement: a preliminary step to build a quality improvement community of practice for pharmacy professionals (SAP-025)
Development and validation of two tools to analyse patients' information needs during the medication dispensing process in Spain (SAP-036)
Development of policies that impact on access to medicines in Angola (SAP-030)
Effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors vs. Dipeptidyl Peptidase-4 Inhibitors in Frail People with Diabetes (SAP-062)
Entrepreneurship in pharmaceutical processes (SAP-022)
Evaluating self-medications and cam use during COVID-19 pandemic among students in an Egyptian private university (SAP-023)
Financial management education: an assessment of pharmacy students’ perception, attitudes, and abilities (SAP-001)
Gap analysis of pharmacoeconomics skills provided in the united states professional pharmacy education (SAP-002)
Humanitarian logistics management practice, performance and challenges of public health emergency pharmaceuticals: the case of selected governmental organizations in Ethiopia (SAP-058)
Impact of drug policy on the consumption of original and generic antihypertensive drugs (SAP-056)
Impact of internet gaming disorder on the body weight status of health science students (SAP-004)
Impact of national public policies on the development of interprofessional education and collaboration (SAP-031)
Impact of pharmacist counselling on medication-related fall risk awareness among community-dwelling older adults in Saudi Arabia (SAP-003)
Implementation of electronic prescriptions during the COVID-19 pandemic in the social security subsystem (SAP-009)
Implementing a cluster-RCT of a community pharmacist-led intervention to support consumers living with severe and persistent mental illness: bridging the gap between physical and mental illness (PharMIbridge) (SAP-011)
Implementing a pharmacy-led sexual risk reduction education initiative for adolescents (SAP-016)
Knowledge, attitude and practices about antimicrobial resistance and antimicrobial stewardship among the general public - poster presentation (SAP-028)
Mask-19 against gender-based violence from pharmacies (SAP-020)
Medication management in frail older people: consensus principles for clinical practice, research, and education (SAP-032)
Medicine shortages: product life cycle phase and characteristics of medicines in short supply – a register study (SAP-051)
Outpatient antibiotic prescribing during the first two years of the COVID-19 pandemic - a nationwide register-based study (SAP-029)
Patient preferences and cost-benefit of hypertension and hyperlipidaemia collaborative management model between pharmacies and primary care in Portugal: a discrete choice experiment alongside a trial (USFarmácia®) (SAP-013)
Patient-centred training for pharmaceutical good distribution practice in pharmacy of your choice (POYC) (SAP-018)
Patients’ opinions of pharmaceutical services in a tertiary hospital pharmacy in Nigeria (SAP-043)
Perceptions of clinical pharmacy roles among healthcare practitioners in Ghana (SAP-006)
Perceptions of the dimensions of complexity within pharmacy amongst UK early career pharmacists (SAP-010)
Personalizing preventive care among older multimorbid adults: development and internal validation of a life expectancy estimator (SAP-021)
Pharmacists’ involvement in the prevention and chronic management of hypertension in low-middle income countries (LMICs): a case study in Ghana (SAP-007)
Pilot framework for applying FIP development goals in your organisation (SAP-038)
Plugging the gap – person-centred approaches to medication management for people with severe mental illness (SMI): the mediate study (SAP-033)
Risk minimisation strategies through drug utilisation review (SAP-034)
Singapore drug supply resiliency: COVID-19 outbreak and beyond (SAP-060)
Strategy to empower pharmaceutical sciences students to engage in the future of the profession (SAP-039)
Strengthening human resource capacity for health product logistics through engagement of training schools: the pharmacists council of Nigeria experience (SAP-044)
Surviving COVID-19 pandemic: pharmacist's experience from a tertiary care health system, kingdom of Saudi Arabia (SAP-054)
The budgetary impact of alemtuzumab in multiple sclerosis in Quito, Ecuador. Payer’s perspective (SAP-045)
The community and hospital pharmacy role in aotearoa New Zealand’s COVID-19 vaccination programme. (SAP-024)
The ethics guideline for prescribing off-label medicines: compilation and development (SAP-050)
The impact of community pharmacies on regional equity in access to professional rapid antigen testing for sars-cov-2 in Portugal (SAP-049)
The influence of COVID-19 on the availability and affordability of essential medicines: insights from Ghana’s national health insurance scheme (NHIS) (SAP-035)
The overview of orphan drug utilization in Taiwan in 2020 (SAP-026)
Vaccine hesitancy in cancer patients: identifying factors (SAP-017)
Validation of quality indicators for geriatric pharmacotherapy in primary care: a mixed-methods study (SAP-052)
What are the pedagogical modalities preferred by community pharmacists for their continuing professional education? (SAP-008)
Digital
September 19
A high tacrolimus intrapatient variability is associated with adverse kidney transplant outcomes (EPS-02)
An exploratory examination of association of catechol-O-methyltransferase gene variants and neonatal abstinence syndrome outcomes (EPS-11)
Effect of dual trigger on pregnancy outcome in patients with ovarian hyperresponse in GnRH antagonist protocol (EPS-03)
Effectiveness of hospital pharmacist interventions for COPD patients: a systematic literature review (EPS-09)
Exploration and practice of doctor-pharmacist cooperation in antimicrobial therapy for gynecologic oncology patients after surgery (EPS-10)
Medication use evaluation: Ceftazidime-Avibactam combination therapy compared to Ceftazidime-Avibactam monotherapy (EPS-01)
Novel tyrosine kinase inhibitor sulfatinib for the treatment of neuroendocrine neoplasms (EPS-04)
Optimization of medications by pharmacists in the respiratory care ward (EPS-08)
Pharmacy practice of pain management and perioperative nausea and vomiting in thoracic surgery (EPS-05)
Prevalence of pethidine prescriptions in Taiwan(2008–2018) (EPS-12)
The result of medication related problems evaluated by pharmacists at the Mongolian-Japan Hospital, MNUMS (EPS-07)
The roles of ubiquitin-proteasome system, heat shock protein 70 and regulator of G protein signaling 4 in morphine-induced behavioral sensitization (EPS-06)
Please note that the presentation file is not available yet.
PDF will be available to FIP members and congress participants.